TheraNews
Subscribe

Archive summary Clinical & research

Trump’s drug strategy aims to bolster addiction services — despite gutting government support

The White House’s strategy for tackling the drug and addiction crisis, released this week, sets lofty public health goals but highlights deep inconsistencies with the administration’s own funding cuts and other policies.

Summary of reporting by headtopics 2 min read Markdown

The White House released a 195-page National Drug Control Strategy on May 4 calling for ambitious public health goals including making treatment more accessible than obtaining drugs, preventing young people from developing addictions, and reducing overdose deaths. However, public health experts note significant inconsistencies between the strategy’s objectives and the administration’s concurrent funding cuts and policy changes.

Treatment Access Challenges

A central goal of the strategy, mentioned at least half a dozen times, is to make treatment easier to obtain than illegal drugs. However, the administration’s Medicaid work requirements in the One Big Beautiful Bill Act are projected to strip coverage from about 1.6 million people with substance use disorders when implemented. One analysis estimated these Medicaid changes could lead 156,000 people to lose access to medications for opioid use disorder and result in more than 1,000 additional fatal overdoses per year. The last time Medicaid rolls were purged after COVID-era protections expired, many people receiving medication treatment for opioid addiction stopped it and fewer people started treatment, according to a study published last year.

Prevention and Harm Reduction Contradictions

The strategy calls for investing in school and community-based prevention programs before drug use starts, citing cost-effectiveness studies. Yet the president’s budget proposes cutting roughly $220 million from SAMHSA’s Center for Substance Abuse Prevention and nearly $40 million from the Drug-Free Communities program. SAMHSA has lost about half of its staff since the administration started. Additionally, SAMHSA announced it would no longer pay for drug test strips, despite the strategy stating “rapid test strips and similar technologies that detect fentanyl and other drugs are an important tool that should be legal.” The strategy calls these contradictions “the height of rhetoric over reality.”


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://us.headtopics.com/news/trump-s-drug-strategy-aims-to-bolster-addiction-services-83185108

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.